Rainmed Medical (02297) disclosed its monthly return for the period ended 31 October 2025, showing no changes in authorized share capital or issued shares. The authorized share capital remained at 3,800,000,000 ordinary shares, each with a par value of HKD 0.0001, totaling HKD 380,000. The number of issued shares also stayed at 1,401,358,800 with none held as treasury shares.

Regarding share options, 22,939,800 options under the Pre-IPO Share Option Scheme adopted on 10 December 2021 continued to be outstanding, with no new shares issued during the month. The company recorded no additional movements or treasury share changes under warrants, convertibles, and other arrangements. All disclosures were confirmed to comply with relevant regulations and requirements.